Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 09, 2015
The United States Pharmacopeial Convention (USP) has announced that Anthony (Tony) Lakavage, J.D., will become Senior Vice President, Global External Affairs, beginning on September 14.
read more
Wednesday, February 17, 2016
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include ...
read more
WellSpring Pharma Services, a specialist in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3 million capital investment in new equipment as well as a new strategic ...
read more
Wednesday, August 03, 2016
Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services. Cytotoxicity studies assess the risk that test articles may cause toxicity in cells, with ...
read more
Thursday, September 01, 2016
Eurofins Scientific has announced the acquisition of VRL Laboratories, one of the leading laboratories in pre-transplant testing for the eligibility determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) in ...
read more
Charles River Laboratories International, Inc. has reported its results for the first quarter of 2016. For the quarter, revenue from continuing operations was $354.9 million, an increase of 10.8% from $320.4 million in the first quarter of 2016.
read more
IntelGenx Corp. announced that it has received an amended Drug Establishment License (“DEL”) from Health Canada, allowing the Company to conduct third-party testing.
read more
As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas.
read more
According to the complaint, despite Delta Pharma’s repeated promises to correct deficiencies, Delta Pharma continued to violate the law.
read more
Thursday, August 13, 2020
Ajinomoto Bio-Pharma has announced an expansion of small molecule manufacturing capabilities with the addition of a new production facility in India.
read more
Wednesday, November 06, 2013
Jason Grenfell-Gardner, President and CEO of the Company, commented, "This submission brings our total number of abbreviated new drug applications on file with the FDA to thirteen. We believe our current pipeline of submissions pending approval by ...
read more
Exscientia announced a strategic research collaboration, and license option agreement with Sanofi in metabolic disease.
read more
Tuesday, October 31, 2017
Citoxlab Group announces the acquisition of Xenometrics, an American CRO specialized in the non-clinical assessment of new drug candidates.
read more
Wednesday, April 15, 2020
Sygnature Group is supporting the Government’s COVID-19 testing strategy with the loan of a key piece of equipment.
read more
Akoya Biosciences announced the appointment of Pascal Bamford, PhD, as Sr. VP, Research and Development and Laboratory Operations. Dr. Bamford will be instrumental in accelerating the innovation of ground-breaking spatial biology solutions and the ...
read more